Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ · Healthcare
Monte Rosa Therapeutics, Inc. Cash on Hand 2023–2025
Monte Rosa Therapeutics, Inc. annual/quarterly cash on hand history from 2023 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Monte Rosa Therapeutics, Inc. cash on hand for the quarter ending December 31, 2025 were 129.9M, a 42.08% decrease year-over-year.
- Monte Rosa Therapeutics, Inc. cash on hand for 2025 were 129.9M, a 42.08% decrease from 2024.
- Monte Rosa Therapeutics, Inc. cash on hand for 2024 were 224.3M, a 75.06% increase from 2023.
- Monte Rosa Therapeutics, Inc. cash on hand for 2023 were 128.1M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Monte Rosa Therapeutics, Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $130 |
| 2024 | $224 |
| 2023 | $128 |
| Monte Rosa Therapeutics, Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $130 |
| 2024-12-31 | $224 |
| 2023-12-31 | $128 |
Monte Rosa Therapeutics, Inc. Cash on Hand — FAQ
Monte Rosa Therapeutics, Inc. (GLUE) cash on hand over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GLUE's cash on hand history?
The chart and table above show Monte Rosa Therapeutics, Inc.'s cash on hand by year and by quarter, including the growth rate.